Author

E. J. Doherty

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1 Organism:plant (other)· 1 Organism:rat· 1

Frequent Co-Authors

D. J. Mooney· 3 shared B. T. Seiler· 2 shared F. Langellotto· 2 shared M. J. Cartwright· 2 shared M. O. Dellacherie· 2 shared M. Super· 2 shared A. G. Stafford· 1 shared A. Li· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. J. Mooney

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A rapidly adaptable biomaterial vaccine for SARS-CoV-2

F. Langellotto, B. T. Seiler, J. Yu, M. J. Cartwright, D. White, C. Yeager, M. Super, E. J. Doherty, D. H. Barouch, D. J. Mooney

This study develops a biomaterial vaccine using mesoporous silica rods to deliver SARS-CoV-2 antigens and adjuvants, showing rapid antibody responses and neutralizing activity.

bioRxiv · Jul 7, 2020 · PreprintImmunology

Single-shot Mesoporous Silica Rods Scaffold for Induction of Humoral Responses Against Small Antigens

M. O. Dellacherie, A. Li, B. Y. Lu, C. S. Verbeke, L. Gu, A. Stafford, E. J. Doherty, D. J. Mooney

This study demonstrates that a single injection of mesoporous silica rods (MSRs) vaccine can generate potent and durable humoral immunity against small antigens like GnRH and Her2/neu peptides.

bioRxiv · Mar 17, 2020Bioengineering

Modular biomaterials vaccine technology protects against multiple pathogens and septic shock

M. Super, E. J. Doherty, M. J. Cartwright, B. T. Seiler, D. A. White, F. Langellotto, A. G. Stafford, N. Dimitrakakis, M. Karkada, A. R. Graveline, C. L. Horgan, K. R. Lightbown, F. R. Urena, C. D. Yeager, S. A. Rifai, , D. J. Mooney

The paper introduces a modular vaccine technology (ciVAX) that protects against multiple pathogens and septic shock by using inactivated bacteria and biomaterial scaffolds.

bioRxiv · Feb 25, 2020 · PreprintImmunology